HPTN Stock Overview
Red Eye Guys Ltd., through its subsidiaries, develops and manufactures Biologix Hair Therapy System, a compound and delivery system to treat follicle nutrient deficiency syndrome (FNDS). More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Happy Town Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0004 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HPTN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | -1.0% |
| 1Y | n/a | -13.9% | 30.3% |
Return vs Industry: Insufficient data to determine how HPTN performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how HPTN performed against the US Market.
Price Volatility
| HPTN volatility | |
|---|---|
| HPTN Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HPTN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HPTN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Michael Stocker | n/a |
Red Eye Guys Ltd., through its subsidiaries, develops and manufactures Biologix Hair Therapy System, a compound and delivery system to treat follicle nutrient deficiency syndrome (FNDS). Its Biologix Hair Therapy System includes Biologix Revive, a hair formula that is administered as a series of shallow injections using a needle targeting the follicles starved by FNDS. Its solution is used to treat reverse and avert FNDS, and alopecia areata.
Happy Town Holdings Inc. Fundamentals Summary
| HPTN fundamental statistics | |
|---|---|
| Market cap | US$56.00 |
| Earnings (TTM) | -US$28.10m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs HPTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPTN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$435.12k |
| Gross Profit | -US$435.12k |
| Other Expenses | US$27.67m |
| Earnings | -US$28.10m |
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HPTN perform over the long term?
See historical performance and comparison